7 of 11 biosimilars approved in Korea were developed by Korean company

Published: 2017-09-07 16:29:00
Updated: 2017-09-07 14:01:22

It was reported there were the total 11 biosimilar products approved in Korea, such as ‘Remsima 100mg,’ and 7 of them were developed by Korean pharmaceutical companies.

According to the Ministry of Food and Drug Safety(MFDS), after Celltrion’s ‘Remsima 100mg’ was first approved as a biosimilar o...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.